Aidoc has gained FDA approval for its new AI-powered solution that helps radiologists flag and triage urgent pulmonary embolism (PE) cases.
The newly approved PE module reads chest CT exams as soon as the patient is scanned and notifies radiologists when necessary. It is now the latest product from Aidoc’s suite of AI-based workflow solutions available in the United States.
“What really excites us about this clearance is that it paves the way towards scalable product expansion,” Elad Walach, Aidoc co-founder and CEO, said in a prepared statement. “We strive to provide our customers with comprehensive end-to-end solutions and have put a lot of effort in developing a scalable AI platform. It took us 18 months to get our first FDA clearance, six for the second one, and we have eight more packages in active clinical trials. I'm excited about what will come next.”
“It is clear that AI will play a tremendous role in the future of radiology,” Daniel J. Durand, MD, chair of radiology at LifeBridge Health in Baltimore, Maryland, said in the same statement. “Considering the complexity of vascular diagnosis, we are eager to see how Aidoc's solutions can benefit our PE patients and bring tomorrow's technology to LifeBridge Health, today.”
Michael has more than 16 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.